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Abstract Admixture mapping is a whole genome asso-
ciation strategy that takes advantage of population his-
tory—or genetic ancestry—to map genes for complex
diseases. However, because it uses racial/ethnic groupings
to examine differential disease risk, admixture mapping
raises ethical and social concerns. While there has been
much theoretical commentary regarding the ethical and
social implications of population-based genetic research,
empirical data from stakeholders most closely involved
with these studies is limited. One of the ﬁrst admixture
mapping studies carried out was a scan for Multiple Scle-
rosis (MS) risk factors in an African-American population.
Applying qualitative research methods, we used this
example to explore developing views, experiences and
perceptions of the ethical and social implications of
admixture mapping and other population-based research—
their value, risks and beneﬁts, and the future prospects of
the ﬁeld. Additionally, we sought to understand how social
and ethical risks might be mitigated, and the beneﬁts of this
research optimized. We draw on in-depth, one-on-one
interviews with leading population geneticists, genome
scientists, bioethicists, and African-Americans with MS.
Here we present our ﬁndings from this unique group of key
informants and stakeholders.
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Introduction
Untangling the genetic, environmental and behavioural
etiologies of complex disease is becoming a research
challenge of global scope. Since the completion of the
Human Genome Project, the ongoing development of
population-based genomic resources (The International
HapMap Consortium 2003; Seguin et al. 2008) is opening
up greater opportunities than ever before for pursuing this
goal (Botstein and Risch 2003; Daar and Singer 2005).
Much of this work relies on studying genetic variation
between groups deﬁned by commonly used racial/ethnic
labels. Thus, the potential to raise ethical and social
problems—for example exacerbating racial/ethnic dis-
crimination and reifying notions of group difference—has
been widely discussed [for review see (Caulﬁeld et al.
2009)]. Controversy on the inter-relationship of genetics,
social identity and health, and their implications seemed to
peak about 5 years ago [for example and review, see the
Nature Genetics supplement ‘Genetics for the Human
Race’ and commentary surrounding the FDA approval of
the ﬁrst ethnic-speciﬁc drug (Sankar and Kahn 2005)].
However, since then and despite the debate, population-
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issues may now be more germane than ever.
A key development in the last 5 years has been tech-
nology allowing high resolution analysis of population
genetic structure (Li et al. 2008). This reiterated earlier
discoveries suggesting that one dimension of genetic
structuring in the human population falls along geographic
or continental lines (Rosenberg et al. 2002). Thus, although
human populations are overwhelmingly similar (Cavalli-
Sforza and Piazza 1975; Jorde et al. 2001), a subset of
genetic variants differ in frequency between groups. This
understanding laid the theoretical and practical foundation
for geographical ancestry-based approaches using ances-
trally-informative genetic markers (AIMs) (Stephens et al.
1994; Collins-Schramm et al. 2002). One example of their
application is admixture mapping (also known as ‘mapping
by admixture linkage disequilibrium’ or MALD), a whole
genome association strategy that takes advantage of the
mixing of geographically-distinct ancestral populations, to
map variants for complex traits (Box 1) (McKeigue 1997;
Smith and O’Brien 2005; Zhu et al. 2008). Used in concert
with other approaches, admixture mapping is starting to
generate important scientiﬁc insights (Reich et al. 2005;
Freedman et al. 2006; Kao et al. 2008; Kopp et al. 2008;
Cree et al. 2009).
Despite extensive literature on the ethical and social
implications of population-based genetic research (Lee
et al. 2001; Burchard et al. 2003; Cooper et al. 2003;
Duster 2005), there is limited empirical data from stake-
holders most closely associated with these studies (Smart
et al. 2006; Fullwiley 2007). One of the ﬁrst admixture
mapping studies carried out was a scan for multiple scle-
rosis (MS) risk factors in an African-American population
(Reich et al. 2005) (Box 2). Applying qualitative research
methods, we used this example to explore developing
views, experiences and perceptions of the ethical and social
implications of admixture mapping and other population-
based research—their value, risks and beneﬁts, and the
future prospects of the ﬁeld. Additionally, we sought to
understand how social and ethical risks might be mitigated,
and the beneﬁts of this research optimized.
To this end, we interviewed a group of key informants
with intimate knowledge of, and/or experience with,
admixture mapping and other population-based genetic
research. We consulted key scientists on the African-
American MS admixture study research team; other lead-
ing geneticists or genome scientists; experts in bioethics
and law; and ﬁnally, to further explore the themes arising,
African-Americans with MS. Excluding the latter group,
these interviewees are representative of those playing a
pivotal role in shaping the direction of current population-
based genetic research. Now, at a time when new tech-
nologies are resolving genetic diversity at ever greater
resolutions, gauging the mindset of these actors is both
timely and important.
Methods
For this study we used qualitative research methods: in-
depth semi-structured interviews, followed by thematic
data analysis (Braun and Clarke 2006) as previously
described (Seguin et al. 2008).
Study sample and research design
We identiﬁed the African-American MS admixture study
as a recent and early example of a genomic mapping
strategy utilizing new population/ancestry-based genetic
methodologies. Twenty-three key informants, including
two African-Americans with MS, were identiﬁed through
purposive and snowball sampling.
The interviews were conducted in three phases. To
begin, we invited members of the African-American MS
admixture study research team—who had designed and
implemented the study, and/or worked closely with
Box 1 What is admixture mapping?
Genetic admixture occurs when two or more populations that have
been separated over long periods of history—often by geography—
come into contact and intermix. For example, the genomes of many
African-Americans, as members of one recently admixed population
in the Americas, are a mosaic of variable proportions of what can be
classiﬁed as European and West African ancestry (Reich et al.
2005). Admixture mapping relies on distinguishing these
chromosomal segments of different ancestry, by the statistical
enumeration of hundreds of ancestrally informative markers (AIMs)
(Stephens et al. 1994; Collins-Schramm et al. 2002; Zhu et al. 2008).
In recently admixed populations these ancestral segments are
extremely long, requiring substantially fewer markers for scanning
the entire genome than other whole genome association studies
(GWAS). This characteristic makes admixture mapping more
economical, more efﬁcient, and theoretically a more powerful
method for identifying common risk factors for complex disease
(Stephens et al. 1994; McKeigue 1997; Collins-Schramm et al.
2002; Hoggart et al. 2004). However, admixture mapping only has
statistical power to identify genetic variants that are differentially
distributed across populations (Rife 1954; Chakraborty and Weiss
1988; Stephens et al. 1994; McKeigue 1997), and relatively few
variants vary in frequency across human groups (Cavalli-Sforza and
Piazza 1975; Jorde et al. 2001). Thus, admixture mapping is a more
specialized method, and likely will only be useful for gene-hunting
in a subset of complex diseases and traits. Nevertheless, the method
has the potential for expansion and improvement. Most notably,
many recently admixed groups exist worldwide, for which sets of
informative AIMs—or admixture mapping panels—have not yet
been constructed. Similarly, there are a considerable number of
complex diseases which differ in prevalence across populations
(McKeigue 1997; Smith and O’Brien 2005). In some cases, genetic
factors may play a role. Thus, admixture mapping in combination
with other methods may be of considerable use going forward.
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123African-Americans with MS and controls—to participate in
the study. Three of the lead scientists on the project agreed
to be interviewed. In the course of these interviewees we
gathered initial study information and ideas.
In the second phase of interviews we used purposive and
snowball sampling to identify individuals who would have
knowledge and informed perspectives on the MS admixture
study, and population-based genetic research. We also used
literature searches to identify potential interviewees, con-
verging on a number of the same individuals. This group
consisted of other geneticists using admixture mapping or
ancestry/population-based approaches in ethnic minorities,
and bioethicists/experts in bioethics and law. These indi-
vidualswere selectedtogainrepresentationonbothsides,or
‘professional standpoints’, in the race/ethnicity and genetics
debate (Lee et al. 2001; Burchard et al. 2003; Cooper et al.
2003; Duster 2005; Holden 2008). Our Research Ethics
Board precluded interviewing the African-American
patients and controls whose DNA samples were actually
scanned in this particular MS admixture mapping study. To
address this limitation, we endeavoured to get a sense of the
perspectives of these research participants, and other Afri-
can-American and Hispanic/Latino individuals who have
participated in other admixture mapping studies, by inter-
viewing researchers (bioethicists and geneticists) who have
directly interacted with them. This was an important con-
sideration in the selection of some of our interviewees. This
secondphaseofinterviewswasusedtoexpand,diversifyand
validate the issues identiﬁed in the ﬁrst phase.
Finally, to further investigate and to validate these per-
spectives, we interviewed two African-Americans with MS
in a third phase of interviews. These individuals, who had
not participated in the MS admixture study, were identiﬁed
through internet searches for support groups for African-
Americans with MS. One said she had heard of the
admixture mapping technique, but not of the African-
American MS Admixture study. The other was not aware
of either. Thus, their knowledge and understanding of
admixture mapping was limited. Nevertheless, these indi-
viduals were able to validate and expand on relevant
information identiﬁed in previous interviews.
In total, we interviewed key geneticists on the African-
American MS admixture mapping project (3) in a ﬁrst
phase, followed by other geneticists/genome scientists
using admixture mapping, ancestry and population-based
approaches (9) and experts in bioethics, or legal scholars
(9) in a second phase, and ﬁnally African-Americans with
MS (2). Overall, our study interviewees represented a
diversity of ethnicities, and relevant disciplinary back-
grounds (Lee et al. 2001; Burchard et al. 2003; Cooper
et al. 2003; Duster 2005; Holden 2008), working in the
United States and Canada.
Data collection
In-depth interviews with key informants were conducted
between August 2007 and March 2010. Interviewees were
asked semi-structured open-ended questions during face-
to-face or telephone interviews that lasted between 45 and
90 min. Interview guides were developed through our
reading of the academic literature; questions focussed on
exploring experiences and perspectives on (1) the actual
preparation, implementation and reporting of the MS
admixture study; (2) ethical, legal, social or cultural issues
raised by the MS study, other admixture mapping studies,
and population-based genetic research in general; (3)
strategies for mitigating the ethical, social or cultural risks
of these studies; (4) opinions on the value, beneﬁts, risks
and future prospects of admixture mapping, as well as on
population-based genetic investigations in general. An
iterative data analysis process was employed where key
issues raised by interviewees were fed into subsequent
interviews. In qualitative research the dataset is consid-
ered complete when a point of theoretical saturation is
Box 2 The African-American multiple sclerosis admixture mapping
study
MS was an ideal disease in which to test the proof of concept for
admixture mapping (Reich et al. 2005). It is a complex disorder
with strong evidence of heritable components. However before
the African-American admixture mapping project, several
decades of concerted research efforts had not revealed new risk
loci. Most importantly with respect to admixture mapping, MS
has a markedly different population prevalence, being extremely
rare in sub-Saharan African groups and predominant in
populations of Northern European descent. In the US, African-
Americans, have a half to a third the relative risk of developing
MS as do European Americans (Wallin et al. 2004). Based on
this well-characterized epidemiology, and the fact that African-
Americans are of mixed European and West African ancestry,
the hypothesis of the MS admixture study was that genetic risk
factors in African-Americans with MS should be of higher
frequency in genomic regions inherited from their European
ancestors. Thus, to localize these risk factors, admixture
mapping scans through the entire genome of African-Americans
with MS searching for regions where the proportion of European
ancestry is higher than average.
To actualize the MS project (Reich et al. 2005), researchers at the
Harvard/MIT ‘s Broad Institute who conceived the admixture
study, partnered with the MS Genetics Group at the University of
California at San Francisco (see: http://www.neurology.ucsf.
edu/msdb/). This group had been gathering self-identiﬁed Afri-
can-American MS cases and controls for some years. The
admixture mapping study produced encouraging results—it
identiﬁed a novel MS risk locus, which was indeed associated
with a local increase in European ancestry. Researchers are now
ﬁne-mapping the locus to pinpoint the genetic variant(s)
responsible for the admixture signal, and it is hoped, to identify a
disease-associated gene, novel molecular mechanisms,
and ultimately, a druggable target for therapeutic
intervention.
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123reached—meaning no new major ideas, information or
themes are emerging from the interviews. This point was
reached at 21 interviews with the key informants. Inter-
views with African-Americans with MS then served to
validate these themes. Interview data was corroborated
using documents such as study consent forms and infor-
mation materials provided by interviewees, and publically-
available materials as were relevant to study questions.
Data analysis
All interviews were digitally-recorded and transcribed
verbatim. These data were analysed using thematic analysis
methods (Ryan and Bernard 2003; Braun and Clarke 2006),
which are well-suited to the analysis of semi-structured
interview data. The process consists of 7 key phases: (1)
familiarization—in which interview data were read in-
depth multiple times; (2) generating initial codes—identi-
fying pieces of data (passages of text) relating to a common
theme or idea; (3) searching for themes and verifying them
across the entire dataset; (4) identifying relationships
between codes, patterns and distinct differences between
subgroups of ideas; (5) deﬁning and naming themes; (6) re-
reading the interviews and modifying codes based on
emerging themes; and ﬁnally (7) mapping, and interpreting
the overall narrative identiﬁed from the data. Atlas Ti 5.2
software was used to organize this process. To maximize
the comprehensiveness and validity of our analysis, inter-
view data were compared and triangulated with informa-
tion gathered from key documents, and were considered in
context of the literature.
Ethics consideration
The study was approved by Research Services, Ethics
Review Unit of the University of Toronto. All interviewees
provided written informed consent.
Results
Our analysis identiﬁed a number of key themes and sub-
themes. We present the following, which were the most
compelling with respect to our research questions; (1)
admixture mapping evokes sensitivities associated with
race; (2) the tendency to see things in terms of race and
ethnicity; and (3) the importance of moving beyond race.
The importance of community engagement (as a mecha-
nism for mitigating the ethical and social risks of popula-
tion-based genetic studies) was also a key theme in the
dataset. However, due to space constriction we have not
reported it herein.
We also note that a few interviewees touched on social
and ethical issues beyond race-related themes. These were;
the need to protect the privacy of research participants, and
the conﬁdentiality of their genetic data; the need to raise
awareness in the general population of the beneﬁts of
genetic research participation; and the ethical implications
of creating unrealistic expectations of imminent health
beneﬁts from the research being conducted during the
process of engaging and recruiting participants. Although
these are all important issues, they were framed by inter-
viewees as more general matters with respect to genetic
research, rather than being speciﬁc to admixture mapping
studies. Perhaps for this reason, they were not the subject
of lengthy or in depth focus, by those that raised them.
Admixture mapping evokes sensitivities associated
with race
Historical and cultural sensitivities
As might be anticipated, when asked about the ethical and
social implications of admixture mapping, the use of race/
ethnicity to group research participants, and to locate dis-
ease-associated genes was a major focus, and source of
concern in almost all of our interviews. As such, intervie-
wees—African Americans with MS, geneticists and bio-
ethicists—said the MS admixture study had the potential to
provoke sensitivities stemming from present and historical
instances of racial inequity and mistreatment, in the United
States.
In particular, the Tuskeegee Syphilis Study (Gamble
1997) was cited by many interviewees as being infamous
amongst African-Americans, and a key signiﬁer of ‘the bad
things that could happen’ out of participating in biomedical
studies. As such, many interviewees felt that there is
widespread distrust of the biomedical research establish-
ment within the African-American community. Several
bioethicists and the African Americans with MS we spoke
to suggested that studies investigating a genetic basis for
racial/ethnic differences between African-Americans and
European Americans may raise particularly deep-seated
concerns about the motives for the research, and the
potential misuse or racial discrimination that could result
from participation.
Population prevalence of MS—stereotyping and inequities
Our analysis indicated that studying MS, which is often
stereotyped as a ‘white disease’, in an African-American
population, raises multiple race/ethnicity-related issues.
Geneticists on the African-American MS admixture study
said a major concern for them was the possibility that
African-Americans might view the study as exploitative,
26 HUGO J (2010) 4:23–34
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African-Americans with MS we spoke to conﬁrmed that
there is heightened potential for community members to
take offense at such a study. They reiterated that there is a
general wariness toward research participation amongst
African-Americans. However, the other major theme in
their interviews was a sense of injustice at inequities in MS
research, treatment, outreach and education between
European populations, and minorities. Many interviewees
noted that historically, MS research has focussed on high
prevalence groups. Likewise, geneticists who have inter-
acted with African-Americans with MS also reported that
community members expressed frustration—particularly
because the MS phenotype is more severe in African-
Americans, than in individuals of Northern European
descent.
Our African-American interviewees expressed a strong
desire to redress inequities in research, including genetic
research, for MS and other conditions affecting their
community. However, while they were keen advocates for
increased involvement of African-Americans in studies,
they emphasized that establishing the trust-worthiness of
researchers is an absolutely fundamental pre-requisite for
participation. Thus, one African-American with MS said:
Doctors and scientists need to learn how to address
their patients’ concerns and communicate the validity
of such a study in a social context that makes their
patients feel comfortable. This should be an integral
part of their research, not just numbers and data but
people.
These sentiments were reiterated by a number of other
interviewees who had interacted directly with African-
American communities involved in the MS and other
admixture studies. Finally, geneticists on the MS admixture
project reported that they have not received negative
feedback about the study from African-Americans. They
attributed this to careful presentation of the study to
potential participants, careful research reporting, the
implementation of community engagement sessions, and
most importantly, to the clear relevance of this admixture
mapping study to African-Americans with MS.
The tendency to see things in terms of race
and ethnicity
Conﬂating ancestry with race
Geneticists we spoke to were quick to emphasize that
admixture mapping is about ancestry—meaning, the pat-
terns of genomic variation shaped by population history—
not race. Thus, one geneticist using admixture mapping
said:
For me the key word is ancestry. I am looking at
ancestry as a tool to discover genes, that’s all that I’m
doing… when you uncouple the issue of ancestry,
where the genes of your ancestors, 5, 6 generations
are coming from, then it is becoming a research tool
and that’s all. And then is when it’s becoming useful.
However, they acknowledged that concepts of race,
ethnicity and ancestry are overlapping, and said they felt
the three are very much conﬂated in the minds of the
public, the media, and even many scientists. No intervie-
wee questioned the veracity of ancestral patterning of
human genetic diversity. Rather, our analysis indicated that
the key ethical issue highlighted by admixture mapping is
the tendency for society to understand population-based
genetic research in terms of race and ethnicity. Geneticists
and bioethicists we spoke to pointed out that the underlying
premise of admixture mapping—that genetic variants are
differentially distributed across population groups—is
easily misinterpreted in ways that objectify race and
encourage stereotyping. For example, the labelling of risk
alleles with ancestry (see Box 1) can easily lead to the
misconception that a detected genetic risk variant is ubiq-
uitous and exclusive to a particular ‘racial’ or ethnic pop-
ulation. Thus, one bioethicist said:
There are some things that are more common in some
populations than others and I don‘t see anything
wrong with studying that. I think the problem is when
we imply that these genes or these variants are unique
to a particular population, as if all the people in that
population have them and all those in another popu-
lation do not.
Most of our interviewees said that the social and ethical
risks of population-based genetic research, including
admixture mapping, are strongly inﬂuenced by the way that
studies are interpreted, reported and ultimately transmitted
through the media to the public. As such, many intervie-
wees—including many of the geneticists themselves—
noted that geneticists need to take particular care with the
interpretation and presentation of admixture mapping
studies to minimize the risk of direct social harms to
research populations through racial stereotyping and stig-
matization, and more broadly to society through the reiﬁ-
cation of race/ethnicity.
Stigmatization and stereotyping were highlighted in our
analysis as serious concerns—researchers working with
African-American cohorts reported that members are
highly sensitized to the potential for these harms. This view
was also emphasized by the African Americans with MS
we spoke to. However, geneticists who have presented
admixture mapping to African-American communities
reported that cohort members, and in one case the
HUGO J (2010) 4:23–34 27
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admixture mapping was appropriate once the rationale for
its use and the underlying science were described. Rather
than being concerned about the methodology itself, their
focus was on preventing misuse of the data. Thus, one
researcher working with African-American groups said:
all cohort responses that we have got in public
meetings have been basically, ‘‘We are not afraid of
information. What we are concerned about is irre-
sponsible interpretation of information’’. And so,
there has not been a great concern about admixture
mapping, per se, but rather for the potential for
misinterpretation.
To date, most if not all other admixture mapping studies
have focussed on diseases that are recognized major health
issues of, and often more prevalent in, African-American
communities (see for example, Zhu et al. 2005; Freedman
et al. 2006; Kao et al. 2008). In the past, instances of group
stigmatization have resulted from association with a dis-
ease-causing variant, after discovery studies in the group in
question (Brandt-Rauf et al. 2006). However, the African-
American MS project presents a different paradigm in that
the detected risk locus is associated with European, rather
than African ancestry. Theoretically then, said some in-
terviewees, the MS study posed less of a risk of stigmati-
zation to African-American groups. We asked geneticists
about the difference in ethical implications between the MS
study and other studies such as the African-American
prostate cancer admixture study (Freedman et al. 2006),
where the self-identiﬁed ethnic identity of the research
population was the same as that of the population of
highest disease prevalence. Geneticists who commented on
this, said they are not different in principle—they felt both
studies are simply using population history to identify
genetic risk factors. Rather, several interviewees—includ-
ing bioethicists and geneticists—pointed out these two
study designs highlight how socio-cultural meanings can
affect the way the public, the media and even scientists
relate to genetic data—and also the importance of thinking
about, and reporting, admixture mapping studies without
objectifying race and ethnicity.
‘Reifying race’ or starting from race?
Opinions on whether admixture mapping ‘reiﬁes race’
varied markedly amongst our interviewees, and were not
clearly polarized by discipline as might have been expected
(Burchard et al. 2003; Duster 2005; Holden 2008). A
number of geneticists ﬂatly disagreed with the notion that
admixture mapping promotes ‘racialized’ understandings.
Instead, they pointed out that it contributes to decon-
structing these concepts by revealing the variety of
ancestries present within what are commonly conceived of
as genetically homogenous ‘races’.
Meanwhile, other interviewees, including bioethicists
and some geneticists, were adamant that any genetic studies
grouping participants by race/ethnicity, reinforce the idea of
these groupings as biologically ‘real’, and genetically dis-
tinct. Bioethicists reiterated that there is a contrast between
geneticists’ professional interpretations of genetic ancestry-
based activities, and non-geneticists’ interpretations of this
work. They noted the latter tend to gravitate towards
familiar frameworks of race, despite attempts to represent it
in more neutral terms. Thus, it was said that despite drawing
attention to the ancestral diversity within populations,
admixture mapping may inadvertently highlight the sal-
ience of race/ethnicity. As such, a few interviewees pointed
out that the AIMs currently used to label ancestry corre-
spond to canonical ‘racial’ groups—African, European,
Asian etc. They suggested that the act of classifying and
labelling genomic segments acts to infer that these groups
once existed as ‘pure’ populations. One geneticist under-
lined this, saying that when he returns genetic ancestry
estimates to research participants, they invariably focus on
‘the numbers’—their African, European, Native American
percentages, rather than appreciating the ‘estimate’ quali-
ﬁer. Thus, taken together a number of interviewees felt that
a major drawback of admixture mapping is that rather than
disrupting concepts of race, it seems to begin with and
reiterate them. In contrast, however, several interviewees
suggested that debates about the reiﬁcation of race have
little relevance outside academic circles. They were of the
opinion that most of the general public already believes in
racial biological differences.
A dominant cultural paradigm
A number of interviewees felt there is an exaggerated focus
on comparing races (and other pre-existing social groups)
within contemporary genetic research. Thus, one geneticist
said:
There’s strong evidence of racial bias that’s internal
to the discipline that hasn’t been addressed within an
ethical framework…and I feel like geneticists have
been woefully—the genetics community—has been
woefully inadequate in addressing that.
Most interviewees held that such a bias was unconscious
on the part of most geneticists, the result of immersion
within a highly ‘racialized’ cultural paradigm in North
America. Several bioethicists noted that geneticists would
be naive to believe that they are immune to such broader
societal perspectives. Many interviewees mentioned the
importance of the media in inﬂuencing public under-
standing of scientiﬁc information. However, most
28 HUGO J (2010) 4:23–34
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icists to critically examine the assumptions underlying the
design (the research questions asked, the populations
sampled and names given to them) and the interpretation of
their studies, and also to be attentive to how ﬁndings are
communicated through the media to society at large. Thus,
while interviewees agreed on the value of continued pop-
ulation-based studies, including admixture mapping, most
heavily underscored the need to proceed with critical self-
awareness and great care. One ethicist said:
Admixture mapping is a legitimate method, with
limitations…I don’t think studying populations reiﬁes
race, I think the ways studies are done sometimes
reiﬁes race, I think how studies are interpreted
sometimes reiﬁes race.
The importance of moving beyond race
All of the geneticists we interviewed employ categories of
race/ethnicity in their genetic studies. Nevertheless, most
expressed discomfort with use of race, and cited social or
scientiﬁc imperatives to move beyond reliance on such
social identity categories for the following; (1) in genetic
research, as a proxy for genetic similarity; (2) conceptually,
as a framework for understanding human genomic varia-
tion; and (3) clinically, to deﬁne disease risk and drug
response. Many interviewees also said that they felt the
tension and differences of approaches between social and
basic scientists, and the socio-political divisiveness that are
evoked by race, are a hindrance to scientiﬁc, as well as
social progress.
However, while looking ahead to an era where the
importance of race is de-emphasized socially and clinically,
many interviewees saw population-based studies in which
social identity is carefully employed, as a transitional step
toward this goal. One geneticist whose work focuses on
African-Americans stipulated he does not study them
assuming they are a homogenous group. Likewise, several
geneticistsspeciﬁedthattheaimoftheirworkinpopulations
is to deconstruct racial health disparities to their genetic,
environmental and behavioural components. They empha-
sized that these groupings, and AIMs, should be regarded as
research tools—a practical means to capture disparities
between populations, and facilitate identiﬁcation of the
ultimate causative factors, with a view ultimately to reduce
inequities. As such, these tools can be used well, or other-
wise. Interviewees strongly cautioned against ‘stopping at
race’, where social identity is used—or implied—to be the
explanation for disease risk or drug response in research
reporting (for further discussion see, Braun et al. 2007;
Ellison et al. 2007; Caulﬁeld et al. 2009). Thus, our inter-
viewees were opposed to the idea of ‘race-based’ medicine.
A good number of interviewees—including bioethicists
and geneticists—were pessimistic that admixture and other
population-based genetic studies per se, in the absence of
societal policies and interventions, could improve the
social problems associated with race. However, they—like
many other interviewees—were strong advocates for con-
certed efforts to ‘move beyond race’. Taken together, our
data suggest that population-based genetic studies now
need to be pushed to ‘the next level’, beyond unquestioning
reliance on social identity alone. Recommendations for
doing so, summarized from our analysis, are presented in
Table 1.
Ancestry—rather than race
Most of our interviewees made a distinction between ‘race’
as a socio-cultural construct, and ‘ancestry’—which they
called a ‘more biological’, empirically-quantiﬁable mea-
sure, that sidesteps the ethical controversies associated with
race. Further, geneticists cited the practical application of
employing ancestry, through the use of AIMs, in their
studies. Thus, they stressed that considering and accounting
for variable ancestry within populations, is becoming an
absolute necessity within contemporary genetic research in
order to correctly analyze genomic data.
A number of geneticists and genome scientists also
speculated on how genomic advances are beginning to
affect our self-identity, and societal concepts of race. They
said they felt that racial categories are becoming ‘out-
moded’. Said one geneticist, ‘I think ethnicity/race is being
redeﬁned and…I think that we are very rapidly being—
coming to be seen as—overlapping, admixed populations,
that all have some things in common’. Several interviews
noted that personal direct-to-consumer ancestry-testing in
particular, is contributing to shifting public understanding,
and dissolving classical notions about racial boundaries.
Overall however, our analysis underscored the relative and
time-dependent nature of racial, ethnic and genetic ances-
try categories. Thus, multiple bioethicists and geneticists
noted that the continental identities assigned to genetic
ancestries reﬂect our contemporary perspective on global
populations. As such, one geneticist summed up the use of
these systems pointing out, ‘… you know any of these
models that consider different parts of the world are false,
in that we’re really all African -all the evidence points
towards a common human origin in East Africa’.
Anchoring population genetics in ancestry
Many interviewees cited the promise of population-based
studies to extend understandings of human disease, physi-
ology, identity and relatedness, and of our species’ place in
the greater web of life on earth. However, to maximize
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terviewees emphasized the importance of promoting public
understanding of genomic diversity that goes beyond
simplistic stereotypes. To do so, the need for a more
nuanced, informed approach to communication and repre-
sentation of research ﬁndings, particularly by geneticists,
was underscored. For example, several geneticists sug-
gested that when addressing the public or the press,
researchers should begin by situating their research in a
global, evolutionary context—emphasizing the recent
common origin of the human species, the genetic similarity
between groups, and explaining the reason for phenotypic
differences between individuals of varying geographical
ancestries. As such, the lead author on the MS study has
explained the admixture method in the press by saying,
‘‘We are asking, if you trace a segment of DNA back six
generations, where did it live, in West Africa or Europe?’’
(see http://genepath.med.harvard.edu/*reich/). Thus, more
proactive communication of research ﬁndings, education of
research populations and the public, and increased oppor-
tunities for public discussion of the links between ‘racial’/
ethnic identity, genetics and health disparities were
emphasized as important strategies by most interviewees.
Some suggested that popular media such as the television
series African-American Lives (see: http://www.pbs.
org/wnet/aalives/), and the availability of personal ances-
try services, are also good exemplars. Likewise, several
geneticists particularly emphasized the ongoing value of
providing such genetics education during community
engagement sessions. Nevertheless, our data indicate such
educational activities need to be expanded, and should be
an ongoing and iterative process.
Discussion
In this study we draw on key informants in the ﬁeld of
population-based genetic research to document developing
perspectives on the ethical and social implications of
admixture mapping, and other genetic studies using social
identity. Our data underscores persistent concerns about the
ethical and social risks of this research, but they also reveal
hopefulness about the potential opportunity offered for
biomedical, and even social, progress. Clearly, our ﬁndings
reﬂect the views of a relatively small sample, of which
many have vested interests in genetic research. However,
we report themes which could be further examined in lar-
ger and more diverse groups of stakeholders, including
non-scientists and members of minority groups. Similarly,
admixture mapping raises social, ethical and other non-
Table 1 Recommendations from our analysis for moving beyond frameworks based on race, in population-based genetic studies
Study framework and design
Consider study designs and groupings that do not rely on race/ethnicity; for example, genotype, disease subtype corrected for genetic
ancestry etc., as appropriate to the research question.
Do not use race/ethnicity as an explanation for biological outcomes; endeavour to identify the ultimate determinants—genetic,
environmental, behavioural etc—of the complex disease or trait in question.
Design inter-disciplinary studies to investigate the full-spectrum of determinants of complex phenotype— environmental, behavioural and
genetic- and the interactions among them.
Where applicable, extend the breadth and depth of human genomic variation studies, encompassing systematic sampling across socio-
political boundaries, within and across socially-identiﬁed groups.
Research interpretation, communication and follow-up
Avoid objectifying race/ethnicity in interpreting admixture mapping and other population-based studies. For example, in reporting admixture
mapping make it clear that the detected risk alleles occur across ‘racial’/ethnic boundaries; and emphasize that population history, rather than
genetic differences between groups, is being used to localize variants more efﬁciently.
Critically examine assumptions about race and ethnicity, including both overt and implicit messages, when designing, interpreting and
communicating studies.
Take into account historical and socio-cultural perspectives on human difference/race/ethnicity.
Provide a population history and bio-geographic ancestry-based framework for population-based genetic studies.
Conduct follow-up studies in multiple populations to validate results from population-speciﬁc investigations, and to fully understand how the
variant(s) inﬂuence the complex trait in question.
Education, training and outreach
Include on research teams individuals with expertise in (1) historical and socio-cultural perspectives on human difference/race/ethnicity; (2)
effective engagement of non-scientist audiences.
Promote the social awareness of geneticists and the media, and greater engagement between these groups.
Encourage the genetic literacy of research communities and the public—with relevant stakeholders including social scientists, bioethicists,
the media, and the public themselves involved, in addition to geneticists.
Create opportunities for open public discourse about the nature of human genomic variation, social identity and health disparities.
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ethnicity. We have reported key themes from our inter-
views herein. That the other issues were not major taking
points may reﬂect the strong feelings that issues of race
evoke, and the tendency for these to override other issues,
at least initially, in discussions about population-based
genetic research, and perhaps particularly in North Amer-
ica. Similarly, it should be noted genetic ancestry testing
was not the focus of this study. However, genetic ancestry
testing, which uses similar technology to admixture map-
ping raises many similar, and some distinct, socio-ethical,
and also economic issues. Notably the advertisement and
return of genetic ancestry testing can represent a key
teachable moment with regards to genetics, population
history and social identity. These issues could be proﬁtably
examined in future study.
Our analysis suggests that stakeholders are aware that
population-based studies, including admixture mapping,
currently rely heavily on socially-constructed concepts of
human groupings, and that they are cognizant of the
inherent risks. However, it seems geneticists and research
participants employ or tolerate these constructs to attain
what they see as greater public good: better biomedical
knowledge and more nuanced understanding of human
genomic diversity. As such, the desire to ‘move beyond’
race was a dominant theme in our dataset. This ﬁnding may
reﬂect some degree of participant bias. However, it is
signiﬁcant as it may indicate a ‘readiness for change’
amongst geneticists, and the likelihood of their uptaking
future policy aimed at minimizing the socio-ethical risks
and maximizing the beneﬁts of population-based studies.
The use of social identity in studies can have unantici-
pated consequences (for review, see Caulﬁeld et al. 2009,
and refs therein). As such, a key contention arising in our
data was whether or not admixture mapping (and more
generally, genetic research that uses social identity) can
assist in moving beyond race. Our analysis suggests this
issue to some degree turns on how studies are designed and
conducted, and particularly how they are interpreted and
communicated to society. Each stage should be imple-
mented with the intention to avoid objectifying social
identity including race/ethnicity, and also ancestry. Nev-
ertheless, as many commentators have noted (for review,
see Caulﬁeld et al. 2009), and as reiterated by our data, it is
extremely difﬁcult to compartmentalize scientiﬁc meanings
and uses of groupings like race or ethnicity from their
social resonances. As such, our study underlines the need
for deepening public understanding of genetics and
ancestry, and for sustained and conscientious efforts
toward challenging and deconstructing stereotypes. How
this could be best achieved warrants further in-depth
investigation. However, while others have published sug-
gestions for the use of race/ethnicity in biomedical research
(Kaplan and Bennett 2003; Condit 2007; Caulﬁeld et al.
2009), we provide recommendations for ‘moving beyond
race’ (Table 1).
Our data suggested that it is incumbent on geneticists, as
the producers of genetic knowledge, to take a leading role
in acting on these recommendations. However, multiple
players inﬂuence the creation of scientiﬁc knowledge, and
its translation, dissemination, and assimilation into popular
consciousness. Thus, the goal of moving beyond race is a
shared responsibility, and should be ‘co-cultivated’ by all
stakeholders—including social scientists, bioethicists,
research funding bodies, journal editorial boards, the media
and the public—in addition to geneticists. More open dis-
course and engagement, and setting and aligning of goals
among these parties, are needed. This could play out in
multiple ways. For example, increased collaboration of
social scientists with basic scientists could synergize on
dissecting biological from environmental determinants of
health disparities, and on translating the ﬁndings into pol-
icy to redress inequities. They might also foster greater
recognition of non-genetic modiﬁers of phenotype, and
facilitate better management of socio-ethical issues and
community engagement. Similarly, interdisciplinary pro-
fessional development workshops between geneticists and
media could promote engagement, instruct on more
nuanced research reporting, and raise awareness of the
societal implications of their work.
An important recommendation arising from our data
was to endeavour to interpret admixture mapping, and
other population-speciﬁc investigations, without objecti-
fying race/ethnicity. However, the ﬁndings of these studies
will often be most applicable to the community in which
the research was done. As others have commented (Dun-
ston 2000; Sharp and Foster 2002), and our data reinforced,
the self-identity of research populations will be an abso-
lutely meaningful aspect of the study to them (see for
example, Jackson Heart Study at http://jhs.jsums.edu/
jhsinfo/). Our analysis emphasized how social meanings
are evoked, and how they must be addressed alongside the
genetics in doing population-based genetics. Thus, the need
for ongoing community engagement—including involve-
ment in the research planning and execution, and consul-
tation with respect to its interpretation—and the vital
importance of researchers (or members of the research
team) having the skill set to communicate with lay audi-
ences about their work, are absolutely fundamental to
maximizing the beneﬁts of these studies.
Many interviewees pointed out that grounding popula-
tion-based studies within a framework of population his-
tory and geographical origin, rather than race/ethnicity,
would assist in redressing some of the ethical and social
concerns arising from this research. In addition, with
regard to admixture mapping, the AIMs used in genetic
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than the current continentally-aligned versions (Novembre
et al. 2008)—thus contributing to deconstructing racial
preconceptions.
With the rapidly growing public health importance of
complex disease and increasing focus on genomics, both
developed and developing countries are undertaking pop-
ulation-based initiatives including admixture mapping
(Smith et al. 2001; Mao et al. 2007; Seguin et al. 2008;X u
and Jin 2008). While personalized or ‘individualized’
genomics has been widely discussed as the ultimate goal of
this work, detected variants will nevertheless fall into
genetic sub-populations, some of which may correlate with
social identity (Palmieri et al. 2008; Lahn and Ebenstein
2009; Li et al. 2009). In addition, the risk associated with
particular genotypes may vary with race/ethnicity (Chris-
tensen et al. 2008). This may be due to the ancestral genetic
background on which the risk factor occurs—what has been
referred to as ‘statistical race’ (Lee 2009). Equally, it may
be due to socio-cultural or environmental factors associated
with the individual’s phenotypic or self-identiﬁed race/
ethnicity. This complexity underlines the importance of
studying the effects of risk variants across populations of
varying geographic ancestry and environments, and reiter-
ates the utility of admixed populations in this regard
(Cooper et al. 2008; Behar et al. 2010). It also underscores
the urgent need to develop effective communication and
education strategies for clinicians, the media, research
participants, and the public about what genetic variation and
ancestry mean, and do not mean, with respect to race.
As more admixture and ancestry-based studies are
published, developing views on these activities, and their
implications, should be monitored. Racial/ethnic discrimi-
nation is a challenge facing societies globally, and if not
checked may translate to inequities in the development of
new treatments, and their application. Our study suggests
the potential of admixture mapping, and other ancestry and
population-based genetic studies, to contribute to improved
social understanding, as well as biomedical progress. A
pragmatic approach—recognizing, accounting for, taking
advantage of and openly talking about the history of pop-
ulations when doing these studies—will allow us to reach
these goals more efﬁciently. Throughout, an ongoing
commitment to challenging assumptions about race and
ethnicity, thoughtful self-awareness and strong ethical
leadership from geneticists, bioethicists and from com-
munities themselves must be essential components of this
work.
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